Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guillevin

Showing results (511-520 of 541) with videos related to

Pageof 55
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 26, 1999
Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virusO Fain, O Lortholary, M Djouab, et al.
Clinical and Experimental Immunology|February 13, 2001
Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE)M A Dragon-Durey, N Rougier, J P Clauvel, et al.
Arthritis and Rheumatism|January 1, 2000
Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study GroupT Généreau, O Lortholary, M A Pottier, et al.
Annales De Medecine Interne|January 1, 1996
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)]P Godeau, F A Allaert, J Barrier, et al.
Journal of the American Society of Nephrology : JASN|June 11, 1999
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritisV Witko-Sarsat, P Lesavre, S Lopez, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesC P Denton, J E Pope, H-H Peter, et al.
Arthritis and Rheumatism|May 28, 2010
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosisJ R Seibold, C P Denton, D E Furst, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Annals of the Rheumatic Diseases|February 3, 2007
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosisP de Groote, V Gressin, E Hachulla, et al.
Pageof 55

Showing results (511-520 of 541) with videos related to

Sort By:
Pageof 55
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 26, 1999
Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virusO Fain, O Lortholary, M Djouab, et al.
Clinical and Experimental Immunology|February 13, 2001
Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE)M A Dragon-Durey, N Rougier, J P Clauvel, et al.
Arthritis and Rheumatism|January 1, 2000
Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study GroupT Généreau, O Lortholary, M A Pottier, et al.
Annales De Medecine Interne|January 1, 1996
[Course of ischemic risk in treated atheromatous hypertensive patients. The PRIHAM study (Prognosis of Ischemic Risk in Atheromatous Patients under Mediatensyl)]P Godeau, F A Allaert, J Barrier, et al.
Journal of the American Society of Nephrology : JASN|June 11, 1999
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritisV Witko-Sarsat, P Lesavre, S Lopez, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesC P Denton, J E Pope, H-H Peter, et al.
Arthritis and Rheumatism|May 28, 2010
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosisJ R Seibold, C P Denton, D E Furst, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Annals of the Rheumatic Diseases|February 3, 2007
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosisP de Groote, V Gressin, E Hachulla, et al.
Pageof 55